Effectiveness of a Single Fixed Dose 3 mg Rasburicase for Prevention and Management of Hyperuricemia of Tumor Lysis Syndrome in adult Cancer Patients
How to cite: Bakhsh, S.; Khan, M. A.; Alshamrani, M.; Mufti, R.; Ansari, A. N.; Almubarak, M.; Alsaeed, A.; Alahmari, M.; Aseeri, M. Effectiveness of a Single Fixed Dose 3 mg Rasburicase for Prevention and Management of Hyperuricemia of Tumor Lysis Syndrome in adult Cancer Patients. Preprints 2024, 2024050962. https://doi.org/10.20944/preprints202405.0962.v1 Bakhsh, S.; Khan, M. A.; Alshamrani, M.; Mufti, R.; Ansari, A. N.; Almubarak, M.; Alsaeed, A.; Alahmari, M.; Aseeri, M. Effectiveness of a Single Fixed Dose 3 mg Rasburicase for Prevention and Management of Hyperuricemia of Tumor Lysis Syndrome in adult Cancer Patients. Preprints 2024, 2024050962. https://doi.org/10.20944/preprints202405.0962.v1
Abstract
Keywords
Subject
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)